All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...822Next →

hiv & aids news selected from other sources

  • New and experimental HIV treatments
    CytoDyn Reports Primary Endpoint Achieved in PRO 140 Pivotal Combination Therapy Trial in HIV Infection
    CytoDyn press release | 6 hours ago

    CytoDyn Inc. (OTC.QB:CYDY) reports the successful achievement of the primary endpoint in its CD02 Phase 2b/3 pivotal clinical trial with PRO 140 in combination with existing antiretroviral therapy (ART) in patients failing their current HIV therapy. The trial data show a statistically significant reduction in HIV-1 RNA viral load of greater than 0.5log with PRO 140 versus placebo. CytoDyn is developing PRO 140, a humanized CCR5 monoclonal antibody, to combat human immunodeficiency virus (HIV) infection and certain immunologic disorders.

  • Activism
    HIV and AIDS activism in Africa
    Posterity Media | 7 hours ago

    Engaging, educating, mobilizing, and empowering people to challenge their governments, donors, allies and funders is the secret to the AIDS activism that brought change in Africa. As young activists now receive classroom training on how to design, plan, implement and monitor activism with timelines, we hope the heat and heart is preserved. As they access large grants and funding for proposal writing, may we remember to teach them that activism is not run by grants, but by people.

  • Recreational drug use
    Struggling With Crystal Meth? There Are Research Studies Out There for You
    The Body | 8 hours ago

    I never thought I would become addicted to methamphetamine when I first used it recreationally 15 years ago, often in combination with MDMA (common known as Ecstasy), to increase my energy and stamina for dancing and celebrating. As a physician, I felt immune to the possibility of having a substance control my behavior.

  • Ageing and HIV
    'The magic of cinema': the club supporting older people with HIV
    The Guardian | 12 hours ago

    The Terrence Higgins Trust initiative aims to combat loneliness and encourage discussion through a shared love of film.

  • Global health initiatives
    More reaction to the Global Fund's partnership with Heineken
    Global Fund Observer | 13 hours ago

    As more reaction to the Global Fund’s partnership with Heineken flowed in, a member of the Global Fund Board has said publicly that he is opposed to the partnership.

  • Infectiousness and treatment as prevention
    Who knows about U=U? Awareness that undetectable individuals do not transmit HIV increasing, says new study
    BETA blog | 13 hours ago

    Recent research, conducted in Vancouver, British Columbia with HIV-positive and HIV-negative men who have sex with men, found that awareness of treatment as prevention is increasing, but still unevenly distributed with HIV-negative men and men with lower social capital less likely to be aware or accepting of treatment as prevention information.

  • Epidemiology and behaviour
    Preventing and treating HIV in Saint Petersburg
    UNAIDS | 13 hours ago

    According to the Centre for AIDS Prevention and Control in Saint Petersburg in the Russian Federation, fewer people are becoming infected with HIV in the city. “Ten years ago, Saint Petersburg was among the top five most affected cities in the Russian Federation. Now it is only the 14th most affected,” said Denis Gusev, Head Physician of the AIDS centre.

  • Condoms and lubricant
    Philippines HIV cases soar 3147% in 10 years as Duterte says condoms 'not satisfying'
    The Independent | 13 hours ago

    Faced with sexual health crisis of epidemic proportions, Philippine President advises against using protection.

  • New and experimental HIV treatments
    Mylan (MYL) Announces Tentative Approval for Combination HIV Treatment DTG/FTC/TAF Under FDA's PEPFAR Program
    Mylan press release | 20 February 2018

    Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced receipt of tentative approval from the U.S. Food and Drug Administration (FDA) under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application for Dolutegravir, Emtricitabine, and Tenofovir Alafenamide Tablets, 50 mg/200 mg/25 mg. The antiretroviral (ARV) will be immediately available in developing countries as a first-line regimen for people being treated for HIV/AIDS.

  • Condoms and lubricant
    Duterte's Condom Criticism Imperils Philippine HIV Fight
    Human Rights Watch | 20 February 2018

    Philippine President Rodrigo Duterte, in a televised speech before Filipino women on February 13, 2018, urged them to not use condoms, comparing usage to eating wrapped candy.

← First12345...14Next →

Conference news

News from the 16th European AIDS Conference (EACS 2017).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

New EUROBulletin

Read the December edition of the Sexual Health & HIV Policy EUROBulletin.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.